Zymergi LogoCart

483 Document: ROSLIN CELL THERAPIES LIMITED, Aug 4, 2023

FDANews 483 ROSLIN CELL THERAPIES LIMITED Aug 4 2023 top
Zhaohui Ye FDA Investigator Carl A. Perez FDA Investigator Gregory A. Price FDA Investigator Jessica Chery FDA Investigator

On Aug 04, 2023, the FDA inspected ROSLIN CELL THERAPIES LIMITED's Edinburgh site. Explore the inspectional observations.